Skip to main content

Health and medicine/Medical specialties/Immunology/Cancer immunology/Cancer immunotherapy

The new studies could pave the way for anti-cancer therapies that control the makeup of these bacterial communities.

A experimental human papilloma virus (HPV) vaccine may be capable of killing cervical cancer cells, according to an early clinical study of the vaccine published in the 10 October issue of the journal Science Translational Medicine.